ArticleHaematologica2019

Response assessment in acute myeloid leukemia by flow cytometry supersedes cytomorphology at time of aplasia, amends cases without molecular residual disease marker and serves as an independent prognostic marker at time of aplasia and post-induction.

Thomas Köhnke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.